Information for Healthcare Professionals about Remdesivir for Injection marketed as Covifor by Hetero Healthcare. This page includes concise information about the Composition, Indications, Uses, Dosage, Storage, and Clinical Data related to the Emergency Use Authorisation medication & COVIFOR. Click here to read more!
Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
Ltd., Ferozsons Laboratories Limited, Mylan N.V., Hovione, Syngene, EVA PHARM, Zydus Cadila., Pfizer Inc., Dr. Reddy’s Laboratories Ltd..
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Remdesivir Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/remdesivir-market/download-sampleMarket Dynamics The global remdesivir market is witnessing dynamic growth.
Remdesivir is broadly used worldwide for treating severe novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2) infection.
Demand for remdesivir has increased worldwide amid the spike in daily cases of COVID-19.
Meanwhile, shortage of supply, black market, and availability of other antiviral drugs substitute FabiFlu, Tocilizumab, and others are factors restraining the demand for Remdesivir.
